the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Ex-company manager fined RM13,000 for using false documents to claim Penjana Prog incentive

KUALA LUMPUR: A former information technology (IT) training company manager was fined RM13,000 by the Sessions Court here today for submitting false documents to Social Security Organisation (Socso) to claim incentives under the Penjana Kerjaraya 2.0 programme amounting to RM9,500, three years ago.

Judge Suzana Hussin imposed the sentence on S. Kamala Segaran, 48 after he pleaded guilty to the three charges and ordered him to serve three months in prison if he fails to pay the fine.

According to all the charges, Kamala Segaran is accused of using three false documents which are Employee Verification Forms of the Hiring Incentive Programme in the name of Tech Train Consultancy to claim incentives under Penjana Kerjaya 2.0 Perkeso amounting to RM9,500, when the employees named in the document are not employees of the company.

All the offences were committed at Wisma Perkeso, Jalan Tun Razak in Kampung Baru here between June 25 and Dec 21 2021.

The charge is under Section 471 of the Penal Code and is punishable under Section 465 of the same code which provides for a maximum prison sentence of two years or a fine or both.

Malaysian Anti-Corruption Commission prosecuting officer Mohd Yasri Yahya asked for the appropriate punishment to teach the accused a lesson.

Lawyer R. Babu Naidu, who represented the accused asked for a minimum fine on the grounds that his client is a single father supporting a six-year-old child and his parents –Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings